Albireo Pharma Inc (ALBO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ALBO | ABUS | AVBP | ||
| Company | Albireo Pharma Inc | Arbutus Biopharma Corp | Arrivent Biopharma Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 44.90 | 4.77 | 22.33 | ||
| High | 44.90 | 4.82 | 22.81 | ||
| Low | 43.99 | 4.66 | 21.81 | ||
| Latest | 44.15 | 4.78 | 21.97 | ||
| Change | -0.10 | -0.01 | -0.32 | ||
| % Change | -0.23% | -0.21% | -1.44% | ||
| Volume | 1,241,200 | 600,200 | 215,300 | ||
| 20-Day Average Volume | 635,260 | 1,242,910 | 443,655 | ||
| Previous Close | 44.25 | 4.79 | 22.29 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 44.18 | 4.56 | 23.11 | ||
| 20-Day Raw Stochastic | 43.90% | 70.56% | 28.84% | ||
| 20-Day Relative Strength | 72.09 | 56.04 | 50.52 | ||
| Weighted Alpha | +16.30 | +56.14 | -11.73 | ||
| Today's Opinion | 88% Buy | 100% Buy | 64% Buy | ||
| Previous Opinion | 100% Buy | 100% Buy | 64% Buy | ||
| Last Month's Opinion | 100% Buy | 64% Buy | 8% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.28% since 02/23/23 | +5.29% since 12/18/25 | +3.78% since 12/18/25 | ||
| Low | 43.53 on 02/24/23 | 4.42 on 12/19/25 | 21.32 on 12/19/25 | ||
| High | 44.90 on 03/02/23 | 4.91 on 12/24/25 | 22.81 on 12/26/25 | ||
| 1-Month | |||||
| %Chg | -0.90% since 02/02/23 | +8.39% since 11/26/25 | -4.69% since 11/26/25 | ||
| Low | 43.31 on 02/23/23 | 4.09 on 12/02/25 | 20.41 on 12/03/25 | ||
| High | 45.23 on 02/03/23 | 5.07 on 12/15/25 | 25.82 on 12/08/25 | ||
| 3-Month | |||||
| %Chg | +85.66% since 12/02/22 | +8.39% since 09/26/25 | +21.85% since 09/26/25 | ||
| Low | 17.78 on 12/27/22 | 4.08 on 11/20/25 | 17.00 on 11/03/25 | ||
| High | 45.23 on 02/03/23 | 5.07 on 12/15/25 | 25.82 on 12/08/25 | ||
| 6-Month | |||||
| %Chg | +156.84% since 09/02/22 | +49.38% since 06/26/25 | -3.68% since 06/26/25 | ||
| Low | 16.02 on 09/07/22 | 3.04 on 06/30/25 | 16.10 on 08/12/25 | ||
| High | 45.23 on 02/03/23 | 5.10 on 09/11/25 | 25.82 on 12/08/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 913,949 | 919,309 | 906,943 | ||
| Shares Outstanding, K | 20,701 | 192,324 | 41,281 | ||
| Annual Sales | 40,580,000 | 6,170,000 | 0 | ||
| Annual Net Income | -34,030,000 | -69,920,000 | -80,490,000 | ||
| Last Quarter Sales | 9,830,000 | 530,000 | 0 | ||
| Last Quarter Net Income | -37,800,000 | -7,740,000 | -34,980,000 | ||
| 60-Month Beta | 1.03 | 0.66 | 0.95 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.89 on 11/08/22 | -0.04 on 11/13/25 | -0.83 on 11/10/25 | ||
| Latest Earnings Date | 03/07/23 | 03/26/26 | 03/02/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||